Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Rentokil Initial plc (NYSE: RTO) provides access to the company’s U.S. regulatory disclosures, including its annual report on Form 20-F and current reports on Form 6-K. As a foreign private issuer and UK-listed company, Rentokil Initial uses these filings to share information with U.S. investors about its global pest control, hygiene and wellbeing operations.
Form 20-F contains detailed information about the group’s business activities, risk factors, governance and financial reporting. For a company operating in around 90 countries and employing more than 60,000 people, this document is a key resource for understanding the structure and scope of its pest control and hygiene services, as well as its North American operations under the Rentokil Terminix brand.
Form 6-K current reports are used to furnish important information that Rentokil Initial releases in other markets. Examples in the available data include notifications of major shareholdings, directorate changes and announcements that the Annual Report and Financial Statements and AGM notices have been filed with the UK Financial Conduct Authority and made available via the National Storage Mechanism. Some 6-K filings also cover matters such as director and related party share dealings in the company’s American Depositary Shares.
On Stock Titan, these filings are updated as they are released through EDGAR and can be paired with AI-powered summaries to help explain complex sections in clearer language. This can be particularly useful when reviewing topics such as major shareholder notifications, governance changes or the structure of Rentokil Initial’s ADS programme, where each ADS represents five ordinary shares. The filings page is therefore a central reference point for investors and researchers seeking a regulatory view of RTO’s global business services operations.
Rentokil Initial plc has appointed Mike Duffy as Chief Executive and Executive Director, effective 16 March 2026, with him joining on 16 February 2026 as CEO Designate. He succeeds Andy Ransom, who will step down as CEO and Executive Director on 16 March 2026 and support a smooth transition through the AGM on 7 May 2026. Duffy, a US-based executive, brings more than 25 years of leadership experience across logistics, truck parts distribution, grocery wholesale and healthcare supply chains.
His remuneration includes an annual salary of US$1,600,000, an annual bonus opportunity up to 225% of base salary, and long-term incentive plan awards up to 375% of base salary, alongside standard benefits and pension. Rentokil Initial will also compensate him for forfeited 2025 bonus and long-term incentives through cash and three replacement share awards with a combined maximum grant date value of US$3.98m, all subject to clawback and malus. The company plans to announce its full-year 2025 financial results on 5 March 2026, with Ransom and CFO Paul Edgecliffe-Johnson presenting before the leadership handover.
Rentokil Initial plc reported that the Samuel J. Mitchell, Jr. Revocable Trust, which is closely associated with non-executive director Samuel Mitchell, purchased 30 American Depositary Shares (ADSs) of the company on 11 August 2025. The ADSs were bought at a price of USD 25.12 per ADS on the New York Stock Exchange.
Each ADS represents five ordinary shares of one pence each in the capital of Rentokil Initial plc. Following this transaction, Samuel Mitchell’s total beneficial ownership in the company is 120 ADSs. The disclosure has been made in line with the requirements of Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc has reported a change in a major shareholding under a TR-1 notification, as furnished on a Form 6-K. A shareholder crossed a disclosure threshold and now holds 3.020865% of Rentokil Initial’s voting rights, corresponding to 76,308,258 voting rights attached to ordinary shares with ISIN GB00B082RF11.
The disclosed position consists entirely of voting rights attached to shares, with no additional voting rights held through financial instruments. This type of notice is a regulatory transparency requirement and indicates an updated ownership level but does not, by itself, describe any transaction terms or changes to Rentokil Initial’s operations or finances.
Rentokil Initial plc reported a notification of major holdings from GIC Private Limited, a Singapore-based investment firm. GIC’s total interest in Rentokil now represents 4.958379% of the company’s voting rights, equal to 125,250,650 voting rights on the date the threshold was crossed.
Of this, 4.670535% of voting rights (117,979,594 voting rights) are attached to ordinary shares, split between direct and indirect holdings, while a further 0.287844% (7,271,056 voting rights) arises from lent securities classified as financial instruments. GIC’s position was previously notified at a higher total of 5.241261%, indicating a reduction that took the holding across a regulatory threshold, requiring this disclosure.
Janus Henderson Group plc filed Amendment No. 4 to Schedule 13G reporting beneficial ownership of 142,436,808 shares of Rentokil Initial plc common stock, representing 5.6% of the class. The filing shows shared voting and shared dispositive power over 142,436,808 shares and no sole power.
Separately, Janus Henderson Investors US LLC (JHIUS) may be deemed the beneficial owner of 127,304,380 shares, or 5.0%, with shared voting and dispositive power. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Rentokil Initial plc reported a TR-1 notification showing GIC Private Limited now holds 5.241262% of voting rights in the company, after crossing a threshold on 24/10/2025.
The position comprises 4.953418% attached to shares and 0.287844% via financial instruments (lent securities), totaling 132,396,361 voting rights. This reflects a decrease from a previously notified 5.908063%. Nominee holders include Vidacos Nominees Limited, Nortrust Nominees Limited, and The Northern Trust Company AVFC.
Rentokil Initial plc furnished a TR-1 major holdings notification via Form 6‑K. BlackRock, Inc. reported total voting rights of 10.020000%, comprising 7.920000% attached to shares and 2.100000% through financial instruments. The filing lists 253,863,914 total voting rights held in the issuer. Previously, the position stood at 9.930000%.
The disclosure itemizes voting rights attached to shares (200,192,027; 7.920000%) and financial instruments including American Depository Receipts (6,342,651; 0.250000%), securities lending (43,609,096; 1.720000%), CFDs (483,540; 0.010000%), and ELNs expiring 11/12/2025 (3,236,600; 0.120000%).
Rentokil Initial plc furnished a TR-1 major holdings notification indicating that BlackRock, Inc. now holds 9.93% of Rentokil’s voting rights in total, down from 10.04% on the previous notification. The filing shows 7.95% of voting rights attached to shares and 1.98% through financial instruments, with 251,543,381 total voting rights held.
Within shares (Section 8A), BlackRock reports 200,968,863 indirect voting rights, representing 7.95%. Financial instruments (Sections 8B1/8B2) include American Depository Receipts of 4,056,466 voting rights (0.16%), securities lending of 42,797,912 (1.69%), CFDs of 483,540 (0.01%), and an ELN of 3,236,600 (0.12%), which together total 1.98%.
Rentokil Initial plc filed a Form 6-K reporting a TR-1 notification that BlackRock, Inc. crossed a major threshold, with total voting rights of 10.040000%.
The position comprises 8.000000% attached to shares, representing 202,271,405 voting rights, and 2.040000% through financial instruments. The instrument mix includes American Depository Receipts at 0.130000% and securities lending at 1.640000%, plus additional instruments (CFDs and ELNs) totaling 0.270000%. In aggregate, BlackRock reported 254,283,199 voting rights.
Previously, the disclosed position was 6.090000% (5.020000% shares and 1.070000% instruments). This filing documents the updated ownership structure and related instrument breakdown.
Rentokil Initial plc reported a steady third quarter, with Group Revenue of $1,810m, up 4.6% year on year, and Organic Revenue growth of 3.4%. North America grew 4.6% with organic growth of 3.4%; North America Pest Control Services rose 1.8%, while Business Services delivered strong momentum with revenue growth of 14.4% (11.9% organic). International revenue increased 4.6% with 3.3% organic growth, helped by solid UK pest control and plants, and strength in Southern Europe. By category, Pest Control organic growth was 3.4% and Hygiene & Wellbeing was 3.0%.
Operational indicators improved: colleague retention reached 81.8% and customer retention 80.9%. The network expanded to 139 satellite branches, with 150 targeted by year end. The sale of the France Workwear business completed at an enterprise value of €410m (c.$480m), generating net cash proceeds of €370m (c.$435m), and quarter-end net debt was $3,865m. Credit ratings remain BBB (stable) from Fitch and S&P. Management said trading is in line with expectations and continues to expect FY 2025 results in line with market expectations.